Major Depressive Disorder

Major Depressive Disorder (MDD) is a severe, chronic mood disorder characterized by persistent feelings of sadness, loss of interest in activities, and significant impairment in social, occupational, and physical functioning.

MDD results from a complex interplay of biological, genetic, psychological, and environmental factors. Key triggers include stressful life events, hormonal shifts, chronic physical illness, and systemic inflammation.

MDD involves dysregulation of monoamine neurotransmitters (serotonin, norepinephrine, dopamine). Neurobiological models implicate the hypothalamic-pituitary-adrenal (HPA) axis hyperactivation, reduced hippocampal volume, and impaired neuroplasticity within the prefrontal cortex and amygdala.

MDD affects approximately 5% of adults globally. It is more common in women than men and frequently manifests in late adolescence or early adulthood.

Genetic predisposition, childhood trauma, history of anxiety, substance use disorders, chronic medical conditions, and lack of social support.

A. Early Symptoms: Persistent fatigue, sleep disturbances, irritability, social withdrawal, loss of appetite.
B. Common Symptoms: Depressed mood, anhedonia (loss of pleasure), feelings of worthlessness, impaired concentration, psychomotor retardation.
C. Advanced Symptoms: Suicidal ideation, nihilistic delusions, severe cognitive impairment, self-neglect.
D. Emergency Symptoms: Active suicidal intent, self-harm, command hallucinations, catatonia.

Vitals may show weight changes. Inspection may reveal poor grooming or slowed psychomotor activity. Auscultation/palpation are typically normal unless comorbid physical disease exists.

A. Clinical Assessment: DSM-5-TR criteria (5+ symptoms for 2 weeks).
B. Laboratory Testing: Thyroid function, CBC, metabolic panel to rule out organic causes.
C. Imaging Studies: Generally not required for diagnosis.
D. Functional Tests: Hamilton Depression Rating Scale (HAM-D).
E. Biopsy Findings: N/A.
F. Genetic Testing: Not clinically routine.
G. Differential Diagnosis: Bipolar disorder, dysthymia, adjustment disorder, medical conditions (e.g., hypothyroidism).

Thyroid Stimulating Hormone (TSH)
Type: Blood Test
Purpose: Rule out hypothyroidism mimicry.
Expected Findings: Elevated or suppressed TSH.
Interpretation: Hyper/Hypothyroidism requires endocrine management.

Brain MRI (Purpose: Rule out structural lesions or mass; Findings: Usually normal; Importance: Essential if neurological deficits exist).

Bipolar disorder (must screen for mania), Hypothyroidism (mimics low energy), Substance-induced mood disorder.

Substance abuse, social isolation, metabolic syndrome, increased cardiovascular risk, suicide.

A. Lifestyle Modifications: Aerobic exercise, sleep hygiene, nutritional support.
B. Preventive Measures: Psychotherapy, stress management.
C. Medical Treatment: SSRIs (Fluoxetine), SNRIs (Venlafaxine), Atypical Antidepressants (Bupropion).
D. Surgical Treatment: Vagus Nerve Stimulation (VNS) for refractory cases.
E. Interventional Procedures: Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS).
F. Rehabilitation: Occupational therapy.
G. Emergency Management: Hospitalization for suicide risk.

Variable; many patients recover with treatment, though recurrence is common. Early intervention improves long-term outcomes.

Early identification of subclinical depressive symptoms, psychotherapy, and mindfulness training.

The following homeopathic remedies have been historically indicated for symptoms associated with Major Depressive Disorder. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 Epworth Sleepiness Scale (ESS)

Evaluates daytime sleepiness levels to screen for sleep apnea, narcolepsy, or chronic sleep deprivation disorders.